{"nct_id":"NCT02603107","title":"Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2015-11-20","start_date_type":"ACTUAL","primary_completion_date":"2017-05-15","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}